SI
SHOULDER INNOVATIONS, INC.
There isn't enough reported data to score SI yet.
SI Fundamentals
| Metric | Status |
|---|---|
| Healthy | |
| Weak | |
| Weak | |
| Unavailable |
SI's revenue is currently healthy, but its profitability and cash flow are weak. There isn't enough data to rate its balance sheet.
SI PE Valuation
SI has no meaningful PE right now: it lost money over the past year.
SI Forward outlook
| Metric | Outlook |
|---|---|
| -- | |
| Losses steady | |
| Strong growth | |
| Strongly improving | |
| Limited | |
| High |
Analysts expect SI's revenue to grow and its profitability to improve, with its earnings holding steady.
SI Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Q1 2025 | -$0.83 | -$0.20 |
| Q4 2024 | -$0.78 | -$0.14 |
SI lost $0.83 per share over the past year, a bigger loss than the year before.
SI Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $16.2M | +38% |
| Q2 2026 | $17.2M | +56% |
| Q1 2026 | $16.7M | +65% |
| Q4 2025 | $14.4M | +65% |
| Q3 2025 | $11.8M | +58% |
| Q2 2025 | $11M | +33% |
| Q1 2025 | $10.1M | +41% |
| Q4 2024 | $8.7M | +28% |
SI's revenue has grown year over year every quarter since early 2024: $16M last quarter, up 38% from the same quarter a year ago.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | -47% | +18 points |
| Q2 2026 | -58% | -5.2 points |
| Q1 2026 | -54% | -11 points |
| Q4 2025 | -59% | -18 points |
| Q3 2025 | -65% | -13 points |
| Q2 2025 | -53% | -5 points |
| Q1 2025 | -42% | +2.9 points |
| Q4 2024 | -41% | -5.3 points |
SI's operating margin was −47% last quarter, up 18 points from the same quarter a year ago.
SI Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | -$7M | +$4.4M |
| Q1 2026 | -$15.1M | -$7.8M |
| Q1 2025 | -$7.3M | -$2.5M |
SI has burned cash in almost every quarter: −$43M over the past year, against −$27M the year before.
SI Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | +0.5% | +109K shares |
| 1 year | +4.6% | +921K shares |
| 3 years | +4.6% | +921K shares |
SI has 21M diluted shares, up 4.6% from a year ago.
| Quarter | Spent |
|---|---|
| Q1 2025 | — |
| Q2 2024 | — |
| Q1 2024 | — |
SI Net Leverage
SI's operating earnings (EBITDA) were negative over the past year, so its debt can't be measured against them.
SI Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 57.4 | Neutral |
| Stochastic | 52.6 | Neutral |
SI's weekly RSI is 57 (neutral) and its Stochastic is 53 (neutral).
SI PE vs Healthcare Sector
SI has no meaningful PE right now: it lost money over the past year.
SI Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $19.1 | 10% above |
| 20 week MA | $20.0 | 5.3% above |
| 50 week MA | $16.9 | 25% above |
SI is in an uptrend: it's above all three of its weekly moving averages, and 25% above its 50-week average.
SI Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2025 | $14.3 | $15.3 | +7% |
| 2026 YTD | $15.3 | $21.1 | +38% |
SI has finished every year since 2025 higher, and it's up 38% so far in 2026.